Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 1.47 USD Market Closed
Market Cap: 63m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+351%
Revenue
Forecast
N/A
Operating Income
Forecast
-20%
Net Income
Forecast
-7%

Wall Street
Price Targets

RPTX Price Targets Summary
Repare Therapeutics Inc

Wall Street analysts forecast RPTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RPTX is 6.63 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

RPTX Lowest Forecast
Wall Street Target
5.05 USD
244% Upside
RPTX Average Forecast
Wall Street Target
6.63 USD
351% Upside
RPTX Highest Forecast
Wall Street Target
8.4 USD
471% Upside
Lowest
Price Target
5.05 USD
244% Upside
Average
Price Target
6.63 USD
351% Upside
Highest
Price Target
8.4 USD
471% Upside
Repare Therapeutics Inc Competitors:
Price Targets
AGIO
Agios Pharmaceuticals Inc
66% Upside
688331
RemeGen Co Ltd
25% Downside
QURE
Uniqure NV
119% Upside
PRAX
Praxis Precision Medicines Inc
127% Upside
AGIO
Agios Pharmaceuticals Inc
66% Upside
688331
RemeGen Co Ltd
25% Downside
QURE
Uniqure NV
119% Upside
PRAX
Praxis Precision Medicines Inc
127% Upside
P
PRME
Prime Medicine Inc
349% Upside
I
IVACC
Intervacc AB
555% Upside
VRTX
Vertex Pharmaceuticals Inc
16% Upside
H
301207
Hualan Biological Bacterin Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Repare Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Repare Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Repare Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
RPTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
RPTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RPTX stock valuation using valuation multiples.
Wall Street Estimates
RPTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RPTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RPTX's stock price target?
Price Target
6.63 USD

According to Wall Street analysts, the average 1-year price target for RPTX is 6.63 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.